XML 35 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 21,370 $ 19,796 $ 58,429 $ 63,931
General and administrative 4,356 3,774 13,992 11,911
Total operating expenses 25,726 23,570 72,421 75,842
Loss from operations (25,726) (23,570) (72,421) (75,842)
Other income (expense):        
Interest income 776 766 2,961 2,534
Change in fair value of the tranche rights 0 0 (4,796) 0
Other income (expense), net 582 35 (1,076) 1,268
Total other income (expense) 1,358 801 (2,911) 3,802
Net loss $ (24,368) $ (22,769) $ (75,332) $ (72,040)
Net loss per share, basic (in USD per share) $ (0.24) $ (0.51) $ (0.75) $ (1.63)
Net loss per share, diluted (in USD per share) $ (0.24) $ (0.51) $ (0.75) $ (1.63)
Weighted-average common shares outstanding, basic (in shares) 101,272,580 44,574,377 99,998,245 44,227,264
Weighted-average common shares outstanding, diluted (in shares) 101,272,580 44,574,377 99,998,245 44,227,264